-+ 0.00%
-+ 0.00%
-+ 0.00%

Is Salesforce (CRM) Undervalued Following Strong Earnings, Higher Guidance And The Claudeforce Launch?

Simply Wall St·09/01/2026 03:16:09
Listen to the news

Salesforce (CRM) has become a focus for investors after a strong Q2 fiscal 2027 earnings report, higher full year guidance and the launch of Claudeforce with Anthropic, which highlights growing traction in its AI platforms.

The recent Q2 fiscal 2027 beat, higher full year guidance, and Claudeforce launch have been followed by sharp share price momentum, with Salesforce posting a 7-day share price return of 23.2% and a 30-day share price return of 40.0%, even though the 1-year total shareholder return is closer to flat at 1.4%.

Scan the AI momentum in enterprise software by checking out hand picked 55 AI infrastructure stocks that echo the kind of agentic and data platforms driving the recent move by Salesforce.

Bulls see Salesforce’s AI platforms and earnings beat as justifying the sharp rerating. Bears point to a stock up around 40% in a month and only modest 1-year returns. Which side does the current valuation support next?

Most Popular Narrative: 1% Overvalued

The most followed Salesforce valuation narrative pegs fair value at about $255.90, almost in line with the last close of $257.54. That tight gap puts the focus on how the business earns its cash flows rather than on a big pricing mismatch.

The per-seat licence was only ever the toll booth. The asset is the governed system of record: every customer, every deal, every entitlement, for about 80% of the Fortune 500. And the one thing an autonomous AI agent cannot do is act on a customer without getting into that record first. An agent with no permissions, no governance and no audit trail is not an asset, it is a liability waiting to happen. So the same automation wave that threatens the seat count is exactly what drives every serious enterprise deeper into the data layer Salesforce owns. The meter changes from per-person to per-action. It does not disappear.

Read the complete narrative.

Want to see how this narrative for Salesforce turns recurring revenue, margin discipline and AI driven usage into that fair value estimate? The full story connects a changing billing model, long term cash flows and a specific future earnings multiple into one clear number.

Result: Fair Value of $255.90 (ABOUT RIGHT)

Have a read of the narrative in full and understand what's behind the forecasts.

However, investors still need to watch for pressure on Salesforce from competing AI platforms, as well as any signs that recurring revenue or customer retention start to weaken.

Find out about the key risks to this Salesforce narrative.

Another View on Salesforce Using Market Ratios

While the most popular Salesforce narrative lands near fair value, the current P/E ratio of 21.9x tells a different story. It is well below the US Software industry average of 31.8x and the peer average of 45.9x, and also below the fair ratio of 33.6x, which the market could move towards. That gap suggests investors are still pricing in some execution or sustainability risk despite recent momentum. How much weight do you want to give that discount versus the narrative that Salesforce is roughly priced right?

For a closer look at how this pricing gap ties back to earnings and potential re rating risk, check the detailed valuation breakdown, including how current multiples compare with long run norms for similar companies, in the See what the numbers say about this price — find out in our valuation breakdown.

NYSE:CRM P/E Ratio as at Sep 2026
NYSE:CRM P/E Ratio as at Sep 2026

Next Steps

With sentiment on Salesforce clearly mixed, it helps to move fast, test the data for yourself, and form a view that fits your risk tolerance using the 3 key rewards and 2 important warning signs

Looking for more investment ideas beyond Salesforce?

If you stop with Salesforce, you risk missing other stocks that could fit your goals. Put a few minutes into fresh ideas that match your style.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.